EE200300024A - Meetod 2-(6-asendatud-1,3-dioksaan-4-üül)etaanhappe derivaadi valmistamiseks, lähteühend ning lõppsaadused - Google Patents

Meetod 2-(6-asendatud-1,3-dioksaan-4-üül)etaanhappe derivaadi valmistamiseks, lähteühend ning lõppsaadused

Info

Publication number
EE200300024A
EE200300024A EEP200300024A EEP200300024A EE200300024A EE 200300024 A EE200300024 A EE 200300024A EE P200300024 A EEP200300024 A EE P200300024A EE P200300024 A EEP200300024 A EE P200300024A EE 200300024 A EE200300024 A EE 200300024A
Authority
EE
Estonia
Prior art keywords
substituted
preparation
acetic acid
formula
group
Prior art date
Application number
EEP200300024A
Other languages
English (en)
Estonian (et)
Inventor
Hermanus Mattheus Hero Kooistra Jacob
Josephus Marie Zeegers Hubertus
Mink Daniel
Maria Cornelis Antonius Mulders Joannes
Original Assignee
Dsm N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm N.V. filed Critical Dsm N.V.
Publication of EE200300024A publication Critical patent/EE200300024A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30Oxygen atoms, e.g. delta-lactones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/041,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/061,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/29Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982Particulate matter [e.g., sphere, flake, etc.]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Catalysts (AREA)
EEP200300024A 2000-07-19 2001-07-12 Meetod 2-(6-asendatud-1,3-dioksaan-4-üül)etaanhappe derivaadi valmistamiseks, lähteühend ning lõppsaadused EE200300024A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL1015744A NL1015744C2 (nl) 2000-07-19 2000-07-19 Werkwijze voor de bereiding van 2-(6-gesubstitueerde-1,3-dioxan-4-yl) azijnzuurderivaten.
PCT/NL2001/000535 WO2002006266A1 (en) 2000-07-19 2001-07-12 Process for the preparation of 2-(6-substituted-1,3-dioxane-4-yl)acetic acid derivatives

Publications (1)

Publication Number Publication Date
EE200300024A true EE200300024A (et) 2004-10-15

Family

ID=19771761

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300024A EE200300024A (et) 2000-07-19 2001-07-12 Meetod 2-(6-asendatud-1,3-dioksaan-4-üül)etaanhappe derivaadi valmistamiseks, lähteühend ning lõppsaadused

Country Status (29)

Country Link
US (4) US6870059B2 (cs)
EP (2) EP1317440B1 (cs)
JP (2) JP5006499B2 (cs)
KR (3) KR100865016B1 (cs)
CN (3) CN100378091C (cs)
AT (1) ATE340790T1 (cs)
AU (2) AU2001275830B2 (cs)
BR (1) BR0112535A (cs)
CA (1) CA2415963C (cs)
CY (1) CY1105881T1 (cs)
CZ (1) CZ302718B6 (cs)
DE (1) DE60123444T2 (cs)
DK (1) DK1317440T3 (cs)
EE (1) EE200300024A (cs)
ES (2) ES2272506T3 (cs)
HU (1) HUP0303166A3 (cs)
IL (3) IL153980A0 (cs)
IS (2) IS2386B (cs)
MX (1) MXPA03000498A (cs)
NL (1) NL1015744C2 (cs)
NO (1) NO328935B1 (cs)
NZ (1) NZ523703A (cs)
PL (1) PL207115B1 (cs)
PT (1) PT1317440E (cs)
RU (1) RU2266903C2 (cs)
SK (2) SK287756B6 (cs)
UA (1) UA77944C2 (cs)
WO (1) WO2002006266A1 (cs)
ZA (1) ZA200300478B (cs)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0011120D0 (en) 2000-05-09 2000-06-28 Avecia Ltd Process
NL1015744C2 (nl) 2000-07-19 2002-01-22 Dsm Nv Werkwijze voor de bereiding van 2-(6-gesubstitueerde-1,3-dioxan-4-yl) azijnzuurderivaten.
AU2002318041B2 (en) 2001-07-13 2008-01-03 Astrazeneca Uk Limited Preparation of aminopyrimidine compounds
EP1323717A1 (en) * 2001-12-27 2003-07-02 Dsm N.V. Process for the preparation of 2-(6-Substituted-1,3-Dioxane-4-yL) acetic acid derivatives
EP1375493A1 (en) * 2002-06-17 2004-01-02 Dsm N.V. Process for the preparation of an dioxane acetic acid ester
GB0218781D0 (en) 2002-08-13 2002-09-18 Astrazeneca Ab Chemical process
AU2003263031A1 (en) * 2002-09-20 2004-04-08 Diversa Corporation Chemoenzymatic methods for the synthesis of statins and stain intermediates
US9740817B1 (en) 2002-10-18 2017-08-22 Dennis Sunga Fernandez Apparatus for biological sensing and alerting of pharmaco-genomic mutation
KR101060215B1 (ko) * 2002-12-16 2011-08-29 아스트라제네카 유케이 리미티드 피리미딘 화합물의 제조 방법
KR20060011984A (ko) * 2003-05-02 2006-02-06 디에스엠 아이피 어셋츠 비.브이. (4-하이드록시-6-옥소-테트라하이드로피란-2-일)아세토니트릴 및 이의 유도체의 제조방법
GB0312896D0 (en) 2003-06-05 2003-07-09 Astrazeneca Ab Chemical process
US8346482B2 (en) * 2003-08-22 2013-01-01 Fernandez Dennis S Integrated biosensor and simulation system for diagnosis and therapy
UY28501A1 (es) 2003-09-10 2005-04-29 Astrazeneca Uk Ltd Compuestos químicos
GB0321827D0 (en) * 2003-09-18 2003-10-15 Astrazeneca Uk Ltd Chemical compounds
GB0324791D0 (en) * 2003-10-24 2003-11-26 Astrazeneca Ab Chemical process
DE10352659B4 (de) * 2003-11-11 2007-09-13 Ratiopharm Gmbh Verfahren zur Herstellung von Statinen und Tetrahydropyranonderivate zur Verwendung in dem Verfahren
GB0428328D0 (en) * 2004-12-24 2005-02-02 Astrazeneca Uk Ltd Chemical process
GB0514078D0 (en) * 2005-07-08 2005-08-17 Astrazeneca Uk Ltd Chemical process
US7264743B2 (en) * 2006-01-23 2007-09-04 Lam Research Corporation Fin structure formation
TW200831469A (en) * 2006-12-01 2008-08-01 Astrazeneca Uk Ltd Chemical process
US20120035374A1 (en) * 2009-04-15 2012-02-09 Pharmathen S.A. Process for the preparation of fluvastatin and salts thereof
GB2482525A (en) * 2010-08-05 2012-02-08 Phoenix Chemicals Ltd A process for the production of acyloxymethyldioxanylacetic derivatives
SI2614057T1 (sl) 2010-09-09 2016-03-31 Dsm Sinochem Pharmaceuticals Netherlands B.V. Soli estrov 7-amino-3,5-dihidroksi heptanojske kisline
EP2616454B1 (en) 2010-09-16 2015-04-15 DSM Sinochem Pharmaceuticals Netherlands B.V. Esters of hexanoic acids as intermediates for the preparation of atorvastatin
MX2013008285A (es) 2011-01-18 2013-09-13 Dsm Sinochem Pharm Bv Procedimiento para la preparacion de diolsulfonas.
HUE025730T2 (en) 2011-01-18 2016-04-28 Dsm Sinochem Pharm Nl Bv A method for producing statins using a base
WO2012098050A1 (en) 2011-01-18 2012-07-26 Dsm Sinochem Pharmaceuticals Netherlands B.V. Methyltetrazole sulfides and sulfones
MX363563B (es) * 2011-12-09 2019-03-27 Dsm Sinochem Pharm Nl Bv Proceso para la preparación de un tioprecursor de estatinas.
EP2788342B1 (en) 2011-12-09 2018-01-24 DSM Sinochem Pharmaceuticals Netherlands B.V. Process for the preparation of a statin precursor
JP6065862B2 (ja) * 2013-04-10 2017-01-25 信越化学工業株式会社 パターン形成方法、レジスト組成物、高分子化合物及び単量体
WO2014203045A1 (en) 2013-06-20 2014-12-24 Lupin Limited A novel, green and cost effective process for synthesis of tert-butyl (3r,5s)-6-oxo-3,5-dihydroxy-3,5-o-isopropylidene-hexanoate
CN105624127B (zh) * 2014-10-28 2019-07-26 上海弈柯莱生物医药科技有限公司 一种葡萄糖脱氢酶及其在合成他汀类药物中间体中的应用

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US544390A (en) * 1895-08-13 Chimney-cowl
GB885516A (en) 1958-01-16 1961-12-28 Arthur Henry Clarkson Higher fatty acid esters of dextran
US3325466A (en) * 1961-01-11 1967-06-13 American Cyanamid Co Tertiary butyl group as a carboxyl protecting group in the synthesis of peptides
US3992432A (en) * 1967-04-05 1976-11-16 Continental Oil Company Phase transfer catalysis of heterogeneous reactions by quaternary salts
DE3929913A1 (de) * 1989-09-08 1991-04-04 Hoechst Ag 4-hydroxytetrahydropyran-2-one sowie die entsprechenden dihydroxycarbonsaeurederivate, salze und ester, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel, pharmazeutische praeparate sowie vorprodukte
GB9005966D0 (en) * 1990-03-16 1990-05-09 May & Baker Ltd New compositions of matter
CA2048716A1 (en) * 1990-08-17 1992-02-18 William B. Mattingly, Iii Absorbent articles with integral release system and methods of making same
JP3097143B2 (ja) * 1991-02-21 2000-10-10 チッソ株式会社 生理活性物質合成用光学活性化合物の製造法および光学活性中間体化合物
US5292891A (en) * 1991-02-21 1994-03-08 Chisso Corporation Optically active 2,2-dimethyl-1,3-dioxin-4-ones and method for preparing same and method for preparing optically active compound for synthesis of physiologically active substance and optically active intermediate compound
WO1993006235A1 (en) * 1991-09-20 1993-04-01 Zeneca Limited Process for the preparation of enantiomerically pure 4-hydroxytetrahydro-2-pyranone derivatives
WO1993008823A1 (en) * 1991-11-06 1993-05-13 Tanabe Seiyaku Co., Ltd. Guanidinyl and related cell adhesion modulation compounds
US5278313A (en) * 1992-03-27 1994-01-11 E. R. Squibb & Sons, Inc. Process for the preparation of 1,3-dioxane derivatives useful in the preparation of HMG-COA reductase inhibitors
FR2696460B1 (fr) * 1992-10-05 1994-11-25 Rhone Poulenc Rorer Sa Procédé de préparation de dérivés du taxane.
US5449793A (en) * 1993-06-04 1995-09-12 Chisso Corporation Process for producing an optically active 1,5-disubstituted-2,4-O-isopropylidene-2,4-dihydroxypentane
US5795749A (en) 1995-04-05 1998-08-18 The Scripps Research Institution Use of 2-deoxyribose-5-phosphate aldolase to prepare 2-deoxyfucose, analogues and derivatives
GB9523924D0 (en) 1995-11-23 1996-01-24 Zeneca Ltd Production of optically active 2-substituted tetrahydropyran-4-ones
US6278001B1 (en) 1995-11-28 2001-08-21 L'oréal Method for preparing (+) compactin and (+) mevinolin analog compounds having a β-hydroxy-δ-lactone grouping
FR2741620B1 (fr) * 1995-11-28 1997-12-26 Oreal Procede de preparation de composes a groupement beta-hydroxy -delta-lactone analogues de la (+) compactine et de la (+) mevinoline
ES2207202T3 (es) * 1998-04-30 2004-05-16 Kaneka Corporation Procedimiento para producir derivados de acido 6-cianometil-1, 3-dioxano-4-acetico.
CN1162422C (zh) * 1998-08-05 2004-08-18 钟渊化学工业株式会社 制备光学活性的2-[6-(羟甲基)-1,3-二噁烷-4-基]乙酸衍生物的方法
HUP0103021A3 (en) * 1998-12-10 2002-04-29 Kaneka Corp Process for producing simvastatin derivatives
GB9903472D0 (en) 1999-02-17 1999-04-07 Zeneca Ltd Chemical process
HU227840B1 (en) 1999-05-06 2012-05-02 Egis Gyogyszergyar Nyilvanosan M Kod Ruszvunytarsasag Intermediates of atorvastatin synthesis and process for producing them
JP4659309B2 (ja) * 1999-06-04 2011-03-30 株式会社カネカ 5−ヒドロキシ−3−オキソペンタン酸誘導体の製造法
AU2000254249A1 (en) * 2000-03-28 2001-10-08 Biocon India Limited Synthesis of (r-(r*,r*))-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-
GB0011120D0 (en) * 2000-05-09 2000-06-28 Avecia Ltd Process
DE60124907D1 (de) * 2000-06-05 2007-01-11 Kaneka Corp VERFAHREN FÜR DIE HERSTELLUNG VON OPTISCH AKTIVEN 2-i6-(HYDROXYMETHYL)-1,3-DIOXAN-4-YLöESSIGSÄURE-DERIVATEN (19.12.01)
NL1015744C2 (nl) 2000-07-19 2002-01-22 Dsm Nv Werkwijze voor de bereiding van 2-(6-gesubstitueerde-1,3-dioxan-4-yl) azijnzuurderivaten.
AU2002318041B2 (en) * 2001-07-13 2008-01-03 Astrazeneca Uk Limited Preparation of aminopyrimidine compounds
EP1323717A1 (en) 2001-12-27 2003-07-02 Dsm N.V. Process for the preparation of 2-(6-Substituted-1,3-Dioxane-4-yL) acetic acid derivatives
EP1478650B1 (en) 2002-02-25 2009-09-30 Biocon Limited Novel boronate esters
KR100511533B1 (ko) 2002-04-09 2005-08-31 임광민 키랄 중간체, 그의 제조방법 및 그를 이용한 HMG-CoA환원저해제의 제조방법
EP1375493A1 (en) 2002-06-17 2004-01-02 Dsm N.V. Process for the preparation of an dioxane acetic acid ester
GB0218781D0 (en) * 2002-08-13 2002-09-18 Astrazeneca Ab Chemical process
KR101060215B1 (ko) * 2002-12-16 2011-08-29 아스트라제네카 유케이 리미티드 피리미딘 화합물의 제조 방법
WO2004103977A2 (en) 2003-05-21 2004-12-02 Ciba Specialty Chemicals Holding Inc. Process for the preparation of pyrimidine derivatives
GB0312896D0 (en) 2003-06-05 2003-07-09 Astrazeneca Ab Chemical process
WO2004113314A1 (en) 2003-06-23 2004-12-29 Biocon Limited Novel boronate esters
UY28501A1 (es) 2003-09-10 2005-04-29 Astrazeneca Uk Ltd Compuestos químicos
GB0321827D0 (en) 2003-09-18 2003-10-15 Astrazeneca Uk Ltd Chemical compounds
GB0324791D0 (en) 2003-10-24 2003-11-26 Astrazeneca Ab Chemical process
CA2645396A1 (en) 2003-12-24 2005-07-14 Teva Pharmaceutical Industries, Ltd Process for preparation of statins with high syn to anti ratio
JP4266879B2 (ja) 2004-05-12 2009-05-20 大阪瓦斯株式会社 ガス化炉及び複合リサイクル装置
US7161004B2 (en) 2004-06-21 2007-01-09 Dr. Reddy's Laboratories Limited Processes to produce intermediates for rosuvastatin
GB0428328D0 (en) * 2004-12-24 2005-02-02 Astrazeneca Uk Ltd Chemical process
GB0514078D0 (en) * 2005-07-08 2005-08-17 Astrazeneca Uk Ltd Chemical process
TW200831469A (en) * 2006-12-01 2008-08-01 Astrazeneca Uk Ltd Chemical process

Also Published As

Publication number Publication date
DE60123444D1 (de) 2006-11-09
IL177824A0 (en) 2006-12-31
KR20070121063A (ko) 2007-12-26
NO20030025D0 (no) 2003-01-03
EP1700854B1 (en) 2012-05-23
CZ302718B6 (cs) 2011-09-21
AU2001275830B2 (en) 2006-07-20
ATE340790T1 (de) 2006-10-15
IS6680A (is) 2003-01-15
NL1015744C2 (nl) 2002-01-22
IL153980A0 (en) 2003-07-31
NO328935B1 (no) 2010-06-21
CN101081842A (zh) 2007-12-05
PT1317440E (pt) 2007-01-31
US6870059B2 (en) 2005-03-22
IL153980A (en) 2006-10-05
DK1317440T3 (da) 2007-01-08
NZ523703A (en) 2004-08-27
JP2004504315A (ja) 2004-02-12
HUP0303166A2 (hu) 2003-12-29
JP5006499B2 (ja) 2012-08-22
CZ2003163A3 (cs) 2003-05-14
ES2272506T3 (es) 2007-05-01
SK287755B6 (sk) 2011-08-04
HK1097260A1 (en) 2007-06-22
CA2415963A1 (en) 2002-01-24
BR0112535A (pt) 2003-07-01
UA77944C2 (en) 2007-02-15
EP1317440B1 (en) 2006-09-27
CN100378091C (zh) 2008-04-02
ES2387313T3 (es) 2012-09-20
EP1317440A1 (en) 2003-06-11
US20100136339A1 (en) 2010-06-03
SK287756B6 (sk) 2011-08-04
IS8690A (is) 2007-11-15
US7989643B2 (en) 2011-08-02
IS2386B (is) 2008-07-15
US20110251406A1 (en) 2011-10-13
CA2415963C (en) 2008-02-26
KR20030040224A (ko) 2003-05-22
DE60123444T2 (de) 2007-08-23
MXPA03000498A (es) 2003-06-24
KR20080078925A (ko) 2008-08-28
PL359332A1 (en) 2004-08-23
SK352003A3 (en) 2003-05-02
HUP0303166A3 (en) 2005-11-28
US20050148785A1 (en) 2005-07-07
AU7583001A (en) 2002-01-30
NO20030025L (no) 2003-01-03
RU2266903C2 (ru) 2005-12-27
JP2012111757A (ja) 2012-06-14
EP1700854A1 (en) 2006-09-13
CN101081842B (zh) 2012-01-04
ZA200300478B (en) 2004-01-26
KR100865016B1 (ko) 2008-10-23
WO2002006266A1 (en) 2002-01-24
CN1680363A (zh) 2005-10-12
CN1443183A (zh) 2003-09-17
PL207115B1 (pl) 2010-11-30
CY1105881T1 (el) 2011-02-02
US7642363B2 (en) 2010-01-05
US20030158426A1 (en) 2003-08-21

Similar Documents

Publication Publication Date Title
EE200300024A (et) Meetod 2-(6-asendatud-1,3-dioksaan-4-üül)etaanhappe derivaadi valmistamiseks, lähteühend ning lõppsaadused
KR100208867B1 (ko) 광학활성 퀴놀린메발론산의 디아스테레오머염
RU2003104825A (ru) Способ получения производных 2-(6-замещенной-1, 3-диоксан-4-ил) укусной кислоты
BR0109048A (pt) Processo para a sìntese de citalopram
JPS61118366A (ja) 2−メチルジヒドロピリジン誘導体の中間体
IS2477B (is) Aðferð til að framleiða díoxanediksýruestera
US4550191A (en) Process for preparing esters of 2'-(6'-methoxy-2-naphthyl)-propionic acid
KR970701711A (ko) 농업용으로 유용한 화학적 중간체(chemical intermediates useful in agriculture)
WO2002024625A3 (en) Process for the preparation of 3-aryl-2-hydroxy propanoic acid derivatives
ATE286870T1 (de) Verfahren zur herstellung von estern
IL131177A (en) Process for the preparation of nicotinic acids and esters
EP1375492A4 (en) PROCESS FOR PREPARING (DIOXOLENONE-4-YL) METHYL ESTERS DERIVATIVES
ATE425972T1 (de) Verfahren zur herstellung substituierter imidazolderivate und in dem verfahren verwendete zwischenprodukte
PL173073B1 (pl) Sposób wytwarzania estrów alkilowych kwasu tetronowego
PL326563A1 (en) Method of obtaining derivatives of methoxyiminophenyglyoxalic acid
KR950013084B1 (ko) 나프탈렌 유도체의 제조방법
SE8302158D0 (sv) Verfahren zur herstellung von 1-alkyl-5-aroyl-pyrrol-2-essigseure-derivaten
KR970010737A (ko) 2-(4-아세틸아미노벤조일아미노)벤즈아미드 유도체, 그 제조방법 및 그를 함유하는 진통제
KR910018345A (ko) 치환 및 비치환 n-히드록시-2-아미노부탄 이산 유도체 및 퀴놀린 유도체의 제조방법